Preferred Label : pristinamycin;
MeSH definition : An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is
a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from
STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC.;
CISMeF synonym : aventis brand of pristinamycin;
MeSH hyponym : pyostacine; RP 7293; RP7293;
Wikipedia link : https://en.wikipedia.org/wiki/Pristinamycin;
Is substance : O;
Origin ID : D025762;
UMLS CUI : C0205996;
ATC code(s)
Allowable qualifiers
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is
a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from
STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC.
https://medqual.fr/images/GP/ATB/2024-_PRISTINAMYCINE.pdf
2024
France
drug information
popular works
Pristinamycin
pristinamycin
---
https://sante.fr/pristinamycine-0
2019
false
false
false
France
French
patient education handout
anti-bacterial agents
pristinamycin
---
https://www.has-sante.fr/portail/jcms/c_2875365/fr/pyostacine
2018
false
false
false
France
pristinamycin
insurance, health, reimbursement
treatment outcome
evaluation of the transparency committee
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60452558
2014
summary of product characteristics
tablets
pristinamycin
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60452558
2013
France
summary of product characteristics
tablets
pristinamycin
---
http://www.lecrat.eu/?s=Pristinamycine
2013
France
French
antibiotic therapy
pregnancy
pristinamycin
anti-bacterial agents
administration, oral
pristinamycin
drug information
---
http://www.has-sante.fr/portail/jcms/c_1332090/pyostacine
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/pyostacine_17102012_avis_ct_12174.pdf
http://www.has-sante.fr/portail/jcms/c_532409/pyostacine
http://www.has-sante.fr/portail/jcms/c_399757/pyostacine-250mg-comprime-pellicule-b/16
2012
France
French
antibiotic therapy
evaluation of the transparency committee
pristinamycin
pristinamycin
administration, oral
insurance, health, reimbursement
anti-bacterial agents
maxillary sinusitis
acute disease
pneumonia, bacterial
community-acquired infections
skin diseases, bacterial
soft tissue infections
disease progression
bronchitis, chronic
bronchitis, chronic
---
http://www.has-sante.fr/portail/jcms/c_1332077/pristam
http://www.has-sante.fr/portail/jcms/c_1335839/pristam-500-mg-17102012-avis-ct-12487
2012
France
French
antibiotic therapy
evaluation of the transparency committee
pristinamycin
administration, oral
pristinamycin
pristinamycin
treatment outcome
anti-bacterial agents
anti-bacterial agents
maxillary sinusitis
acute disease
bronchitis, chronic
disease exacerbation
disease progression
community-acquired infections
pneumonia, bacterial
soft tissue infections
skin diseases, bacterial
risk assessment
---